Villalva-Serra Klauss, Barreto-Duarte Beatriz, Rodrigues Moreno M, Queiroz Artur T L, Martinez Leonardo, Croda Julio, Rolla Valeria C, Kritski Afrânio L, Cordeiro-Santos Marcelo, Sterling Timothy R, Araújo-Pereira Mariana, Andrade Bruno B
Curso de Medicina, Universidade Salvador, Salvador, Brazil.
Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil.
Lancet Reg Health Am. 2024 Dec 11;41:100963. doi: 10.1016/j.lana.2024.100963. eCollection 2025 Jan.
Despite government efforts, tuberculosis (TB) remains a major public health threat in Brazil. In 2023, TB incidence was 39.8 cases per 100,000 population, far above the WHO's target of 6.7 cases per 100,000. Using national-level datasets, we investigated and forecasted the potential impact of proposed public health interventions aimed at reducing TB incidence in Brazil.
Monthly TB surveillance data (January 2018-December 2023) were collected from Brazilian national reporting systems: SINAN-TB (TB cases), SITE-TB (TB drug resistance), and IL-TB (preventive therapy). These data were used to create a multivariable Bayesian Structural Time-Series (BSTS) model, with 5000 Monte-Carlo simulations, which identified key predictors of TB incidence and forecasted these rates from 2024 to 2030 under various scenarios.
Vulnerabilities including incarceration, TB-HIV coinfection and TB-diabetes mellitus, as well as coverages of directly observed therapy (DOT), contact investigation and preventive treatment (TPT) completion rates, were identified as key predictors of TB incidence. Under current trends, we forecasted TB incidence in Brazil to be 42.1 [34.1-49.8] per 100,000 person-years by 2030 (mean [95% prediction intervals]). A scenario considering decreases in TB cases among vulnerable populations resulted in an absolute reduction of -10.6 [-9.4 to -12.0] in projected TB incidence. Additional reductions were seen with increased coverage of DOT, TPT adherence, and contact investigation rates (-14.4 [-13 to -16.2]), and by combining these with efforts to reduce TB cases among vulnerable populations (-23.6 [-26.3 to -41.4]), potentially lowering incidence to 18.5 [7.8-28.4] per 100,000, though still above WHO targets.
Our findings demonstrate that interventions focused on enhancing health policies focused on decreasing TB cases among vulnerable populations, such as individuals with TB-HIV coinfection, incarcerated populations, and those with TB-diabetes comorbidity, along with improvements in health management indicators such as DOT implementation, contact investigation coverage, and TPT completion rates, are effective in reducing TB incidence nationwide.
Oswaldo Cruz Foundation.
尽管政府做出了努力,但结核病在巴西仍然是一个重大的公共卫生威胁。2023年,结核病发病率为每10万人39.8例,远高于世界卫生组织每10万人6.7例的目标。我们利用国家级数据集,调查并预测了旨在降低巴西结核病发病率的拟议公共卫生干预措施的潜在影响。
从巴西国家报告系统收集了2018年1月至2023年12月的月度结核病监测数据:SINAN-TB(结核病病例)、SITE-TB(结核病耐药性)和IL-TB(预防性治疗)。这些数据用于创建一个多变量贝叶斯结构时间序列(BSTS)模型,并进行5000次蒙特卡洛模拟,该模型确定了结核病发病率的关键预测因素,并预测了2024年至2030年不同情景下的发病率。
包括监禁、结核病与艾滋病病毒合并感染、结核病与糖尿病合并感染等脆弱性因素,以及直接观察治疗(DOT)覆盖率、接触者调查和预防性治疗(TPT)完成率,被确定为结核病发病率的关键预测因素。按照当前趋势,我们预测到2030年巴西结核病发病率将为每10万人年42.1[34.1 - 49.8]例(均值[95%预测区间])。考虑到脆弱人群中结核病病例减少的情景,预计结核病发病率将绝对降低-10.6[-9.4至-12.0]。DOT覆盖率、TPT依从性和接触者调查率提高后,发病率进一步降低(-14.4[-13至-16.2]),将这些措施与减少脆弱人群中结核病病例的努力相结合(-23.6[-26.3至-41.4]),发病率可能降至每10万人18.5[7.8 - 28.4]例,尽管仍高于世界卫生组织的目标。
我们的研究结果表明,针对加强卫生政策的干预措施,重点是减少脆弱人群(如结核病与艾滋病病毒合并感染患者、被监禁人群以及结核病与糖尿病合并症患者)中的结核病病例,同时改善卫生管理指标,如DOT实施情况、接触者调查覆盖率和TPT完成率,在全国范围内降低结核病发病率方面是有效的。
奥斯瓦尔多·克鲁兹基金会。